Latest by Myles Helfand
Primary care + HIV care = improved health care engagement; the efficacy of different HIV testing and treatment interventions; abdominal fat and hypertension rates; the ethics of HIV phylogenetics.
Whether a local HIV outbreak in Tijuana, Mexico, may be related to police activity; PrEP and stigma in hookup apps; HIV, aging, and the immune system; cannabis as a systemic anti-inflammatory.
Long-term glucose disorders; anal vs. cervical HPV; PrEP adherence among U.S. veterans; economic incentives to spur HIV testing.
The effect of HIV treatment on HPV risk; bone mineral density declines in women vs. men; how hep C cure affects kidney function; when it comes to non-daily PrEP, location matters.
The risks of multiple non-HIV medication prescriptions; PrEP use and sexually transmitted infection incidence; how vaginal bacteria relate to HIV seroconversion; the effect of early treatment on HIV in the brain.
Gauging treatment priority when CD4 count is high; the effect of hepatitis C coinfection on response to HIV treatment; HIV, aging and comorbidity in Africa; PrEP and drug-resistant gonorrhea.
NeuroAIDS while on efavirenz vs. common NRTIs; HIV and the smoking cessation aid varenicline; PrEP adherence after positive partners start treatment; and Ugandans underreporting their antiretroviral use.
This week: PrEP remains deeply underprescribed in North Carolina; and recent studies explore the effects of inflammation, age, and serum albumin on serious non-AIDS event risk.
This week: the successes of Vancouver's harm reduction and HIV outreach programs; the safety of stem-cell transplantation; how biomarkers predict health events; and how to improve partner notification.
Our latest jaunt through HIV journals looks at a symptom-based scoring system to predict acute HIV, the effect of a person's sex on psychomotor function, and the value of vitamin D supplementation to moderate lipid levels.